Navigation Links
Securus Medical Group Raises $6.5M, Appoints New CEO
Date:10/29/2013

CLEVELAND, Oct. 29, 2013 /PRNewswire-USNewswire/ -- Securus Medical Group, Inc., a privately held medical device company, announced the initial closing of a $6.5 million Series B financing led by new investor 3X5 Special Opportunity Fund, and that Steven Girouard, PhD has been named President and Chief Executive Officer.  A medical device industry veteran, Steve has held executive leadership roles at Johnson & Johnson, Guidant Corporation, Cleveland Clinic and Oakwood Medical Investors.  Existing investor RiverVest Venture Partners, as well as the University of Michigan Investment in New Technology Startups (MINTS) program, also participated in the financing.  Securus plans to use Series B proceeds to further develop their Aurora™ thermographic mapping system, a proprietary thermal measurement device that is expected to have several clinical applications for temperature monitoring during energy-based surgical procedures.  As part of the financing, Nicholas Walrod, Principal of 3X5 Special Opportunity Fund, will join the Board of Directors. 

(Photo: http://photos.prnewswire.com/prnh/20131029/DC05765)  

"We are enthusiastic in our support of Securus and we were delighted to attract Steve to lead the Company during this critical phase of development," said Walrod.  "We see an opportunity for several large medical device markets to benefit from Securus monitoring technology and Steve brings to Securus deep industry insights and a strong network in target markets for the Company." 

Securus plans to maintain its headquarters in Ohio on the campus of Cleveland Clinic's Global Cardiovascular Innovation Center, an early grant-based supporter of the Company.  The Company's 2011 Series A financing was led by RiverVest and included JumpStart and the University of Michigan.

3x5 Special Opportunity Fund, L.P. is a St. Louis and Portland-based, closed-end private investment fund focused primarily on direct investments in later-stage companies within the healthcare and clean-tech sectors. The fund closed in early 2013 at approximately $80 million in committed capital, which it expects to deploy over six portfolio investments.

RiverVest Venture Partners is a venture capital firm focused on identifying and shaping early stage life science companies to create significant shareholder value. With hands-on, high-level expertise and financial resources, RiverVest supports entrepreneurs by helping them achieve near-term objectives that position their companies for exit. For more information, please visit www.rivervest.com.


'/>"/>
SOURCE Securus Medical Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nonin Medical Appoints Richard J. Eagle Vice President of Sales
2. Solta Medical to Report Third Quarter 2013 Results and Host Conference Call on November 11, 2013
3. Utah Hospital Saves Money and the Environment by Treating Its Own Medical Waste on Site
4. Medical Imaging Equipment Market is Expected to Reach USD 35.35 Billion Globally in 2019: Transparency Market Research
5. Epiditi - "COOL THE JEWELS!" The Only Form-Fitting Scrotal Ice Pack on the Planet - Now A Medical Crowdfunding Project
6. Middle Peak Medical Raises an Additional $3M to Develop Novel Mitral Valve Technology
7. Aethlon Medical (AEMD) Note: Cancer Immunotherapy Article, Introduction to Dr. Douglas Taylor
8. Media Sourcerys Secure Mobile Workflow App Deployed by CCS Medical to Expedite Product Delivery to Patients
9. Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2013
10. Varian Medical Systems Schedules Fiscal Year End Review for Investors in New York
11. Boston Scientific Receives Prestigious 2013 Prix Galien Award For Best Medical Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):